Cargando…
Recurring Translocations in Barrett’s Esophageal Adenocarcinoma
Barrett’s esophagus (BE) is a premalignant metaplasia in patients with chronic gastroesophageal reflux disease (GERD). BE can progress to esophageal adenocarcinoma (EA) with less than 15% 5-year survival. Chromosomal aneuploidy, deletions, and duplication are early events in BE progression to EA, bu...
Autores principales: | Bajpai, Manisha, Panda, Anshuman, Birudaraju, Kristen, Van Gurp, James, Chak, Amitabh, Das, Kiron M., Javidian, Parisa, Aviv, Hana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220202/ https://www.ncbi.nlm.nih.gov/pubmed/34178034 http://dx.doi.org/10.3389/fgene.2021.674741 |
Ejemplares similares
-
Barrett’s Epithelium to Esophageal Adenocarcinoma: Is There a “Point of No Return”?
por: Panda, Anshuman, et al.
Publicado: (2021) -
Gene Expression in Barrett’s Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma
por: Panda, Anshuman, et al.
Publicado: (2021) -
Prolonged exposure to acid and bile induces chromosome abnormalities that precede malignant transformation of benign Barrett’s epithelium
por: Bajpai, Manisha, et al.
Publicado: (2012) -
Advances in the management of Barrett’s esophagus and early esophageal adenocarcinoma
por: Singh, Ajaypal, et al.
Publicado: (2015) -
Global DNA methylation patterns in Barrett’s esophagus, dysplastic Barrett’s, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use
por: Kaz, Andrew M., et al.
Publicado: (2016)